Lionsgate Studios Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by Lionsgate Studios Corp. on April 15, 2026, reporting events occurring on April 13, 2026. The filing details amendments to the employment agreement of Jon Feltheimer, the Company's Chief Executive Officer.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements.
Material Changes
The primary material change is the approval of amendments to Mr. Feltheimer's employment agreement, including:
- Term Extension: The agreement term is extended by two years to July 31, 2031.
- One-Time Equity Grant: Mr. Feltheimer received an option to purchase 4,500,000 common shares at $11.07 per share and an award of 666,667 Restricted Stock Units (RSUs).
- Performance Conditions: The one-time grant vests in three tranches contingent on achieving stock price goals of $17.50, $20.00, and $22.50 within five years, alongside continued employment.
- Annual Grants: The agreement establishes annual equity grants for fiscal years 2026 through 2029 with a target grant date value of $10,000,000 per year, subject to performance metrics.
- Compensation Structure: Mr. Feltheimer's annual base salary remains $1,500,000. The target annual performance bonus for the 2025 fiscal year is $7,500,000, with a maximum of 200% of the target.
Outlook, Risks, and Contingencies
Severance Provisions:
- Termination without Cause/Good Reason: Entitles Mr. Feltheimer to the present value of his base salary through the end of the term, 18 months of health coverage, life/disability insurance premiums through the term, and the target annual bonus for the year of termination.
- Change in Control: If termination occurs within 12 months of a change in control, cash severance is the greater of the present value of the base salary through the term or $6,000,000.
- Equity Acceleration: Unvested equity awards generally accelerate upon termination without cause, for good reason, death, or disability. In a change in control, tranches meeting stock price goals become time-based or fully vested.
Risks: The filing notes that the summary is qualified by the full agreement and amendment. The value of the annual grants is contingent on the Company's financial performance against targets to be agreed upon annually.
Investor Verification Checklist
- Verify the total dilution impact of the 4,500,000 options and 666,667 RSUs granted in this amendment.
- Review the specific performance metrics for the $10,000,000 annual grants for fiscal years 2026-2029, as these are to be determined annually.
- Assess the potential cash outflow for severance, specifically the $6,000,000 floor in a change-in-control scenario.
- Confirm the current stock price relative to the $17.50, $20.00, and $22.50 vesting thresholds for the new equity awards.